Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5001
CALL
Fomento Económico Mexicano
FMX
$42.6B
| $165K | ﹤0.01% |
1,800
+1,500
| +500% | +$138K |
|
5002
Mid Penn Bancorp
MPB
$969M
| $165K | ﹤0.01% |
6,421
-1,016
| -14% | -$25.4K |
|
5003
Tiptree Inc
TIPT
$665M
| $165K | ﹤0.01% |
22,692
+5,403
| +31% | +$36.5K |
|
5004
PUT
Amphenol
APH
$199B
| $164K | ﹤0.01% |
6,800
-800
| -11% | -$18.4K |
|
5005
CALL
Designer Brands
DBI
$323M
| $164K | ﹤0.01% |
9,600
+5,400
| +129% | +$91.6K |
|
5006
ProShares Ultra QQQ
QLD
$13.1B
| $164K | ﹤0.01% |
13,544
+4,536
| +50% | +$55.6K |
|
|
NETI
5007
DELISTED
Eneti Inc.
NETI
| $164K | ﹤0.01% |
2,913
-1,231
| -30% | -$69.1K |
|
|
RUBY
5008
DELISTED
Rubius Therapeutics, Inc
RUBY
| $164K | ﹤0.01% |
21,035
-8,778
| -29% | -$102K |
|
|
PCSB
5009
DELISTED
PCSB Financial Corporation
PCSB
| $164K | ﹤0.01% |
8,181
-2,498
| -23% | -$49.4K |
|
|
KDMN
5010
DELISTED
Kadmon Holdings, Inc.
KDMN
| $164K | ﹤0.01% |
65,000
-18,937
| -23% | -$47K |
|
|
CHMI
5011
Cherry Hill Mortgage Investment Corp
CHMI
$84.1M
| $163K | ﹤0.01% |
12,511
-224
| -2% | -$3.17K |
|
5012
CALL
Core Laboratories
CLB
$491M
| $163K | ﹤0.01% |
3,500
-3,200
| -48% | -$149K |
|
5013
NVE Corp
NVEC
$575M
| $163K | ﹤0.01% |
2,451
-640
| -21% | -$43.6K |
|
5014
RBB Bancorp
RBB
$452M
| $163K | ﹤0.01% |
8,246
-2,554
| -24% | -$48.8K |
|
|
SA
5015
CALL
Seabridge Gold
SA
$2.82B
| $163K | ﹤0.01% |
12,900
-4,300
| -25% | -$61.1K |
|
5016
NN Inc
NNBR
$276M
| $162K | ﹤0.01% |
22,943
-4,970
| -18% | -$37.3K |
|
5017
Oragenics
OGEN
$2.26M
| $162K | ﹤0.01% |
167
+56
| +50% | +$46.8K |
|
5018
Sibanye-Stillwater
SBSW
$6.31B
| $162K | ﹤0.01% |
30,034
-227,871
| -88% | -$1.16M |
|
5019
PUT
Zoetis
ZTS
$32.6B
| $162K | ﹤0.01% |
1,300
-1,300
| -50% | -$157K |
|
|
TTOO
5020
DELISTED
T2 Biosystems, Inc
TTOO
| $162K | ﹤0.01% |
13
+1
| +8% | +$8.03K |
|
|
GMLP
5021
CALL
DELISTED
Golar LNG Partners LP
GMLP
| $162K | ﹤0.01% |
16,900
| – | – |
|
|
GMLP
5022
PUT
DELISTED
Golar LNG Partners LP
GMLP
| $162K | ﹤0.01% |
16,900
| – | – |
|
5023
CALL
Valley National Bancorp
VLY
$7.96B
| $161K | ﹤0.01% |
14,800
+9,100
| +160% | +$97.4K |
|
|
RTLR
5024
DELISTED
Rattler Midstream LP Common Units
RTLR
| $161K | ﹤0.01% |
+9,009
| New | +$167K |
|
5025
CALL
MBIA
MBI
$265M
| $160K | ﹤0.01% |
17,300
-2,400
| -12% | -$22.4K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.